ReviewFrontiers in pharmacology2023

Protein tyrosine phosphatase non-receptor type 2 as the therapeutic target of atherosclerotic diseases: past, present and future.

Xiao-Er Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.